CDC ACIP votes to provisionally recommend Merck’s Vaxneuvance in series with Pneumovax 23 EP News Bureau Oct 21, 2021 Series would be routinely recommended both for adults 65 years and older and for adults aged 19 to 64 at an increased risk for…
